Literature DB >> 4422260

Adrenal suppression in the treatment of carcinoma of the prostate.

M R Robinson, R J Shearer, J D Fergusson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4422260     DOI： 10.1111/j.1464-410x.1974.tb03856.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN： 0007-1331


× No keyword cloud information.
  11 in total

Review 1.  Combination therapy in stage C and D prostatic cancer: rationale and five year clinical experience.

Authors:  F Labrie; A Dupont; A Bélanger; L Cusan; M Giguère; Y Lacourcière; I Luthy; D Bégin; C Labrie; J Simard
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 2.  Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer.

Authors:  P E Lønning; S Kvinnsland
Journal:  Drugs       Date:  1988-06       Impact factor: 9.546

Review 3.  The value of myocardial strain imaging in the evaluation of patients with repaired Tetralogy of Fallot: a review of the literature.

Authors:  Panagiotis Zachos; Vasilios Nevras; Nikias Milaras; Maria Karakosta; Alkistis Kalesi; Nearchos Kasinos; Antonios Destounis; Nikolaos L Kelekis; Ignatios Ikonomidis; Dimitrios Niakas
Journal:  Heart Fail Rev       Date:  2022-03-14       Impact factor: 4.214

Review 4.  Aromatase inhibitors in malignant diseases of aging.

Authors:  D C Johannessen; P E Lønning
Journal:  Drugs Aging       Date:  1992 Nov-Dec       Impact factor: 3.923

Review 5.  Castration-resistant prostate cancer: targeting androgen metabolic pathways in recurrent disease.

Authors:  Elahe A Mostaghel; Bruce Montgomery; Peter S Nelson
Journal:  Urol Oncol       Date:  2009 May-Jun       Impact factor: 3.498

6.  The effects of aminoglutethimide and hydrocortisone, alone and combined, on androgen levels in post-orchiectomy prostatic cancer patients.

Authors:  M Dowsett; R J Shearer; B A Ponder; P Malone; S L Jeffcoate
Journal:  Br J Cancer       Date:  1988-02       Impact factor: 7.640

Review 7.  Abiraterone in the treatment of metastatic castration-resistant prostate cancer.

Authors:  Elahe A Mostaghel
Journal:  Cancer Manag Res       Date:  2014-01-28       Impact factor: 3.989

8.  Steroid hormone synthetic pathways in prostate cancer.

Authors:  Elahe A Mostaghel
Journal:  Transl Androl Urol       Date:  2013-09

Review 9.  New developments in the treatment of castration resistant prostate cancer.

Authors:  Roxanne Wadia; Daniel P Petrylak
Journal:  Asian J Androl       Date:  2014 Jul-Aug       Impact factor: 3.285

10.  Response to aminoglutethimide and cortisone acetate in advanced prostatic cancer.

Authors:  B A Ponder; R J Shearer; R D Pocock; J Miller; D Easton; C E Chilvers; M Dowsett; S L Jeffcoate
Journal:  Br J Cancer       Date:  1984-12       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.